Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Alnylam Pharmaceuticals (ALNY) Q3 2023 Earnings
ALNY
3
Aug
Confirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-2.69
-2.26
-1.83
-1.4
Details
Expected EPS
-1.5
Actual EPS
-2.21
Surprise EPS
-0.71
Surprise Percent
+47.33%
Description
Alnylam Pharmaceuticals (ALNY) has reported earnings of -2.21 per share for Q3 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login